Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Dose-ranging Study to Evaluate the Safety and Efficacy of LUSEDRA (Fospropofol Disodium) as an Intravenous Sedative for Diagnostic or Therapeutic Colonoscopy in Adult Special Populations

ClinicalTrials.gov ID: NCT01127438

Public ClinicalTrials.gov record NCT01127438. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of LUSEDRA (Fospropofol Disodium) as an Intravenous Sedative for Diagnostic or Therapeutic Colonoscopy in Adult Special Populations

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of LUSEDRA (fospropofol disodium) and to determine whether a dose lower than currently approved can provide effective moderate sedation required to complete diagnostic or therapeutic procedures.

Study identification

NCT ID
NCT01127438
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Eisai Inc.
Industry
Enrollment
153 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2010 (Type not available)
Primary completion
Jun 2011 (Actual)
Completion
Jun 2011 (Actual)
Last update posted
Feb 8, 2013

2010 – 2011

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
Hope Research Institute Phoenix Arizona 85050 —
Southern California Permanente Medical Group Baldwin Park California 91706 —
Desta Digestive Disease Medical Center San Diego California 92114 —
Washington Hospital Center Washington D.C. District of Columbia 20010 —
Center for Advanced Gastroenterology Maitland Florida 32751 —
University of Miami School of Medicine Miami Florida 33136 —
Miami Research Associates South Miami Florida 33143 —
Sheridan Clinical Research Sunrise Florida 33323 —
Gastrointestinal Specialists of Georgia, PC Marietta Georgia 30060 —
Creighton University Medical Center Omaha Nebraska 68131 —
Research Associates of New York, LLP New York New York 10075 —
Duke University Durham North Carolina 27710 —
Ohio State University Medical Center Department of Anesthesiology Columbus Ohio 43210 —
Ilumina Clinical Associates, Keystone Headache and Pain Mgt Center, Tyrone Hospital Tyrone Pennsylvania 16686 —
Ilumina Clinical Associates Uniontown Pennsylvania 15401 —
Digestive Health Associates Plano Texas 75075 —
Clinical Trial Network Spring Texas 77386 —
Utah Digestive Health Institute Clinton Utah 84015 —
Northern Utah Gastroenterology Logan Utah 84341-2534 —
Advance Clinical Research Odgen Utah 84405 —
Utah Clinical Trials, LLC Salt Lake City Utah 84107 —
Charlottesville Medical Research Charlottesville Virginia 22911 —
Gastroenterology Associates of Northern Virginia Fairfax Virginia 22031 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01127438, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2013 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01127438 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →